1-18 of 18
Loic Chartier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

Clinical Trials & Observations
Camille Laurent, Preeti Trisal, Bruno Tesson, Sahil Seth, Alicia Beyou, Sandrine Roulland, Bastien Lesne, Nathalie Van Acker, Juan-Pablo Cerapio, Loïc Chartier, Arnaud Guille, Matthew E. Stokes, C. Chris Huang, Sarah Huet, Anita K. Gandhi, Franck Morschhauser, Luc Xerri
Journal: Blood
Blood (2024) 144 (24): 2503–2516.
https://doi.org/10.1182/blood.2024024496
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots-Loyer, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Herve Ghesquieres, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Herve Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Françoise Kraeber-Bodéré, Caroline Milin, Jean-Philippe Jais, Josette Briere, Olivier Casasnovas, Salim Kanoun, Emmanuel Itti, Paul Blanc-Durand, Mad-Hélénie Elsensohn, Loic Chartier, Fabrice Jardin, Thierry Fest
Journal: Blood
Blood (2024) 144 (Supplement 1): 575.
https://doi.org/10.1182/blood-2024-202446
Published: 2024
Journal Articles

Outcomes of Patients Treated with Consolidative Brentuximab Vedotin after Transplant for Hodgkin Lymphoma at High Risk of Progression or Relapse: An Innovative Comparative Analysis Based on Propensity Score Weighting from Patients Included in 4 Lysa-Cohorts

Amira Marouf, Cedric Rossi, Tesla Murairi, Fanny Cherblanc, Loic Chartier, Hervé Ghesquieres, Bénédicte Deau Fischer
Journal: Blood
Blood (2024) 144 (Supplement 1): 4424.
https://doi.org/10.1182/blood-2024-209608
Published: 2024
Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua Tobin, Loic Chartier, Brian K. Link, Andrew L. Feldman, Dai Chihara, Carla Casulo, Anne Ségolène Cottereau, Luca Guerra, Joshua Olson, Jason T Romancik, Sara Haddadi, Harrison Black, Thomas Trevis, Eric Mou, Tsz Hung Tong, Kamilia Moalem, Anna M. Johnston, Paul J. Hampel, Jeffrey Johnson, Steinepreis Elizabeth, Pinguang Yang, Serena Kosciejew, Goodall Elizabeth, Kate Manos, Chan Y. Cheah, Ross Salvaris, Thomas M. Habermann, Peter Martin, Brad S. Kahl, Grzegorz S. Nowakowski, Georgina Hodges, Loretta Nastoupil, Dipti Talaulikar, Judith Trotman, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Stefano Luminari, Franck Morschhauser, Stephen M. Ansell, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3007.
https://doi.org/10.1182/blood-2024-202088
Published: 2024
Journal Articles

Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials

Clementine Sarkozy, Loïc Chartier, Vincent Ribrag, Remy Gressin, Christian Geisler, Hanneke Kluin-Nelemans, Catherine Thieblemont, Franck Morschhauser, Corinne Haioun, Violaine Safar, Herve Ghesquieres, Wolframm Klapper, Barbara Burroni, Christiane Pott, Marie-Helene Delfau, Elizabeth A. Macintyre, Mary Callanan, Michael Unterhalt, Eva Hoster, Martin Dreyling, Steven Le Gouill, Olivier Hermine, Morgane Cheminant
Journal: Blood
Blood (2023) 142 (Supplement 1): 299.
https://doi.org/10.1182/blood-2023-173615
Published: 2023
Journal Articles

First Line Therapy Evaluation Using Propensity Score Approach in Newly Diagnosed Advanced Classical Hodgkin Lymphoma Patients from Prospective Real-World Realysa Cohort and Phase 3 AHL2011 Trial

Cedric Rossi, Amira Marouf, Benedicte Deau Fischer, Fanny Cherblanc, Emeline Cugnod, Loic Chartier, Luc Matthieu Fornecker, Marc Andre, Rene-Olivier Casasnovas, Herve Ghesquieres
Journal: Blood
Blood (2023) 142 (Supplement 1): 3056.
https://doi.org/10.1182/blood-2023-178154
Published: 2023
Journal Articles

A Simplified IPI Including BCL2 Identifies IPI 3 Patients with Poor Prognosis - a GLA/ Dshnhl and Lysa Collaboration

Marita Ziepert, Bettina Altmann, Viola Poeschel, Caterina Cristinelli, Loïc Chartier, Nicolas Ketterer, Christian Recher, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Nicolas Mounier, Hervé Tilly, Franck Morschhauser, Andreas Rosenwald, German Ott, Thierry Jo Molina, Georg Lenz, Catherine Thieblemont, Norbert Schmitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 191.
https://doi.org/10.1182/blood-2023-184611
Published: 2023
Journal Articles

Identification and Clinical Characterization of CNS Relapse in DLBCL Patients across 19 Prospective Phase 2 and 3 Trials - a GLA/ DSHNHL and LYSA Collaboration

Fabian Frontzek, Loïc Renaud, Ulrich Duehrsen, Viola Poeschel, Sophie Bernard, Loïc Chartier, Nicolas Ketterer, Christian Recher, Olivier Fitoussi, Gerhard Held, Rene-Olivier Casasnovas, Corinne Haioun, Nicolas Mounier, Hervé Tilly, Franck Morschhauser, Steven Le Gouill, Imke E. Karsten, Gerben Duns, Christian Steidl, David W. Scott, Wolfram Klapper, Andreas Rosenwald, German Ott, Thierry Jo Molina, Georg Lenz, Marita Ziepert, Bettina Altmann, Catherine Thieblemont, Norbert Schmitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 71.
https://doi.org/10.1182/blood-2023-178815
Published: 2023
Journal Articles

Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study

Alexis Claudel, Anne Ségolène Cottereau, Emmanuel Bachy, Pierre Feugier, Rene-Olivier Casasnovas, Corinne Haioun, Herve Tilly, Nicolas Daguindau, Guillaume Cartron, Emmanuelle Nicolas Virelizier, Pauline Brice, Benoit Tessoulin, Christophe Fruchart, Sylvie Glaisner, Alain Jacques Delmer, Emmanuel Fleck, Gian Matteo Pica, Hacene Zerazhi, Stephanie Guidez, Morgane Cheminant, Luc Xerri, Laetitia Vercellino, Loïc Chartier, Lucie Gomes, Pierre-Julien Viailly, Marie-Helene Delfau, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 170.
https://doi.org/10.1182/blood-2023-178030
Published: 2023
Journal Articles

Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study

Krimo Bouabdallah, Raphaëlle Aubrais, Loïc Chartier, Charles Herbaux, Anne Banos, Pauline Brice, Marlene Ochmann, David Sibon, Jean Marc Schiano De Colella, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Marwa Hammami, Eric Durot, Christophe Bonnet, Margot Robles, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie Parrens, Noel-Jean Milpied, Gandhi Laurent Damaj
Journal: Blood
Blood (2021) 138 (Supplement 1): 620.
https://doi.org/10.1182/blood-2021-150953
Published: 2021
Journal Articles

Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Clinical Trials & Observations
Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouhabdallah, Corinne Haioun, Gandhi Damaj, Luc Fornecker, Réda Bouhabdallah, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Loic Chartier, Philippe Ruminy, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette Brière, Jean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti, René-Olivier Casasnovas
Journal: Blood
Blood (2021) 137 (17): 2307–2320.
https://doi.org/10.1182/blood.2020008750
Published: 2021
Includes: Supplemental data
Journal Articles

The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World

Catherine Thieblemont, MD PhD, Loïc Chartier, Ulrich Dührsen, Prof, MD PhD, Umberto Vitolo, MD, Sally F Barrington, Prof, MD PhD, Laetitia Vercellino, Jan Zaucha, MDPhD, Inês Patrocinio Carvalho, Gomes da Silva Maria, MD PhD, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, MD PhD, Alina Berriolo-Riedinger, Rene-Olivier Casasnovas, MD, Andreas Hüttmann, MD, Hajira Ilyas, George Mikhaeel, Prof, MD PhD, Joel Dunn, Anne Ségolène Cottereau, MD, Christine Schmitz, MD, Joseph N. Paulson, Tina G Nielsen, Michel Meignan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136544
Published: 2020
Journal Articles

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

CME Clinical Trials & Observations
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loic Chartier, Christophe Fruchart, Louise Roulin, Lucie Oberic, Gian Matteo Pica, Vincent Ribrag, Julie Abraham, Marc Simon, Hugo Gonzalez, Reda Bouabdallah, Olivier Fitoussi, Catherine Sebban, Armando López-Guillermo, Laurence Sanhes, Franck Morschhauser, Judith Trotman, Bernadette Corront, Bachra Choufi, Sylvia Snauwaert, Pascal Godmer, Josette Briere, Gilles Salles, Philippe Gaulard, Michel Meignan, Catherine Thieblemont
Journal: Blood
Blood (2020) 135 (16): 1396–1405.
https://doi.org/10.1182/blood.2019003526
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of Total Metabolic Tumor Volume at Baseline in the Remarc Study

Anne Ségolène Cottereau, Laetitia Vercellino, Olivier Casasnovas, MD, Herve Tilly, MD, Pierre Feugier, Christophe Fruchart, Louise Roulin, Lucie Oberic, MD, Gian Matteo Pica, MD, Vincent Ribrag, MD, Julie Abraham, MD, Marc Simon, MD, Hugo Gonzalez, Reda Bouabdallah, MD, Olivier Fitoussi, MD, Catherine Sebban, MD, Armando Lopez-Guillermo, Margaret Macro, Laurence Sahnes, Franck Morschhauser, MD, Judith Trotman, Bernadette Corront, Bachra Choufi, Sylvia Snauwaert, Pascal Godmer, Loïc Chartier, Gilles Salles, MD PhD, Josette Briere, MD, Bertrand Coiffier, MD PhD, Michel Meignan, Catherine Thieblemont, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4199.
https://doi.org/10.1182/blood-2018-99-112874
Published: 2018
Journal Articles

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study

Clinical Trials & Observations Brief Report
Anne Ségolène Cottereau, Annibale Versari, Stefano Luminari, Jehan Dupuis, Loïc Chartier, René-Olivier Casasnovas, Alina Berriolo-Riedinger, Massimo Menga, Corinne Haioun, Hervé Tilly, Vittoria Tarantino, Massimo Federico, Gilles Salles, Judith Trotman, Michel Meignan
Journal: Blood
Blood (2018) 131 (22): 2449–2453.
https://doi.org/10.1182/blood-2017-11-816298
Published: 2018
Includes: Supplemental data
Journal Articles

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

Clinical Trials & Observations
Anne-Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, Antonio Castagnoli, Pauline Brice, John Raemaekers, Bénédicte Deau, Catherine Fortpied, Tiana Raveloarivahy, Emelie Van Zele, Loic Chartier, Thierry Vander Borght, Massimo Federico, Martin Hutchings, Umberto Ricardi, Marc Andre, Michel Meignan
Journal: Blood
Blood (2018) 131 (13): 1456–1463.
https://doi.org/10.1182/blood-2017-07-795476
Published: 2018
Includes: Supplemental data
Journal Articles

Low Suvmax Measured on Baseline FDG-PET/CT and Elevated β2 Microglobulin Are Negative Predictors of Outcome in High Tumor Burden Follicular Lymphoma Treated By Immunochemotherapy: A Pooled Analysis of Three Prospective Studies

Anne Ségolène Cottereau, MD, Annibale Versari, MD, Loïc Chartier, Jehan Dupuis, MD, Vittoria Tarantino, MD, Rene-Olivier Casasnovas, MD, Antonella Franceschetto, Emmanuel Itti, MD PhD, Hervé Tilly, MD PhD, Corinne Haioun, MD, Massimo Federico, MD PhD, Alina Berriolo, MD, Gilles Andre Salles, MD PhD, Stefano Luminari, Michel Meignan, MD PhD, Judith Trotman, MBChB
Journal: Blood
Blood (2016) 128 (22): 1101.
https://doi.org/10.1182/blood.V128.22.1101.1101
Published: 2016
Journal Articles

Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies

Michel Meignan, Annibale Versari, MD, Anne Ségolène Cottereau, Loïc Chartier, Jehan Dupuis, MD, Sami Boussetta, Ilaria Grassi, Rene-Olivier Casasnovas, MD, Corinne Haioun, MD PhD, Hervé Tilly, MD PhD, Massimo Federico, Gilles A. Salles, MD PhD, Stefano Luminari, MD, Judith Trotman, MBChB
Journal: Blood
Blood (2015) 126 (23): 3919.
https://doi.org/10.1182/blood.V126.23.3919.3919
Published: 2015